Mucosal Urinary Secretion Revealing Adenocarcinoma of Urachus

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2021 May 17

PMID 33996065

Authors

Issam Jandou

Adnan Ettanji

Ettaouil Mohammed

Amine Moataz

Dakir Mohammed

Adil Debbagh

Rachid Aboutaieb

Affiliations

Soon will be listed here.

Abstract

Introduction: Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still poor.

Presentation Of Case: We report the case of a 50-year-old patient with no pathological history who consulted for an episode of intermittent urinary mucosal secretion aggravated by the appearance of macroscopic hematuria. Without other associated clinical signs. Imaging examinations revealed a mass at the expense of the upper wall of the bladder. The cystoscopy allowed us to visualize the mass and the biopsy. Histological study revealed an adenocarcinoma of urachus. The patient underwent surgical exeresis and adjuvant chemotherapy. The evolution was marked by a deterioration of the general condition despite adequate management.

Discussion: Due to its topography, urachus cancer usually manifests as a bladder tumor, exceptionally as much as an anterior umbilical or extraperitoneal tumor. Few studies have been done on this neoplasm; however surgery still has a primary place in therapeutic management.

Conclusion: The scarcity of cases of urachus cancer makes the publications scarce and the lack of multicenter clinical and randomized trials explains the disagreement about adjuvant treatments.

References

Thali-Schwab C, Woodward P, Wagner B . Computed tomographic appearance of urachal adenocarcinomas: review of 25 cases. Eur Radiol. 2004; 15(1):79-84. DOI: 10.1007/s00330-004-2408-z. View

Nakanishi K, Kawai T, Suzuki M, Torikata C . Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts. Hum Pathol. 1996; 27(3):240-7. DOI: 10.1016/s0046-8177(96)90063-5. View

Descazeaud A . [Urachal diseases]. Ann Urol (Paris). 2008; 41(5):209-15. DOI: 10.1016/j.anuro.2007.08.009. View

Amin M, Smith S, Eble J, Rao P, Choi W, Tamboli P . Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol. 2014; 38(8):1033-45. DOI: 10.1097/PAS.0000000000000250. View

Krysiewicz S . Diagnosis of urachal carcinoma by computed tomography and magnetic resonance imaging. Clin Imaging. 1990; 14(3):251-4. DOI: 10.1016/0899-7071(90)90085-p. View

Vergos M, Messina M, Lhomme Desages B, Chapuis O . [Cancer of the urachus. A rare form of tumors of the bladder]. J Urol (Paris). 1992; 98(1):56-9. View

Jandou I, Ettanji A, Mohammed E, Moataz A, Mohammed D, Debbagh A . Urachal carcinoma revealed by isolated hematuria. Ann Med Surg (Lond). 2021; 63:102193. PMC: 7937653. DOI: 10.1016/j.amsu.2021.102193. View

Jandou I, Wichou E, Ettanji A, Moataz A, Mohammed D, Debbagh A . Hypercalcemia an exceptional complication in upper urinary tract urothelial carcinoma. J Surg Case Rep. 2021; 2021(2):rjaa574. PMC: 7880700. DOI: 10.1093/jscr/rjaa574. View

Sheldon C, Clayman R, Gonzalez R, Williams R, FRALEY E . Malignant urachal lesions. J Urol. 1984; 131(1):1-8. DOI: 10.1016/s0022-5347(17)50167-6. View

10.

Agha R, Franchi T, Sohrabi C, Mathew G, Kerwan A . The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. Int J Surg. 2020; 84:226-230. DOI: 10.1016/j.ijsu.2020.10.034. View

11.

VON GARRELTS B, MOBERG A, Ohman U . Carcinoma of the urachus. Review of the literature and report of two cases. Scand J Urol Nephrol. 1971; 5(1):91-5. DOI: 10.3109/00365597109133584. View

12.

Ashley R, Inman B, Sebo T, Leibovich B, Blute M, Kwon E . Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006; 107(4):712-20. DOI: 10.1002/cncr.22060. View